Application

Western blot: 1-10 µg/mL using ECL.

ELISA: 1:10,000-1:100,000 using 50-100 ng control peptide (Catalog Number AG214) per well.

Optimal working dilutions must be determined by the end user.

Research CategoryNeuroscience

Research Sub CategoryNeuroinflammation & PainNeurotransmitters & Receptors

Detect Cannabinoid Receptor 2 using this Anti-Cannabinoid Receptor 2 Antibody, C-terminus validated for use in ELISA & WB.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Immunogen

Epitope: C-terminus

An 18 amino acid peptide sequence near the cytoplasmic, C-terminus of rat CB2 (Munro et al. 1993; Shire et al. 1996; Griffin et al. 2000).

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Physical form

Affinity purified immunoglobulin. Liquid in phosphate buffered saline, pH 7.4, containing 0.1% BSA.

Specificity

Recognizes rat Cannabinoid Receptor 2 (CB2). The immunogen shows no significant sequence homology with CB1.

SPECIES REACTIVITIES: The immunogen peptide is 88% conserved in mouse and 82% in human. Reactivity with other species has not been confirmed.

Storage and Stability

Maintain at -20°C in undiluted aliquots for up to 6 months. Avoid repeated freeze/thaw cycles.